University of Bristol
Jonathan Reid is Professor of Physical Chemistry at the University of Bristol. His research spans fields extending from atmospheric science to drug delivery to the lungs, the factors controlling the viability of bacteria and viruses in the aerosol phase, and the formulation science of aerosol.
He has published over 140 publications in peer-reviewed journals, is on the editorial board of the Royal Society of Chemistry (RSC) journal Chemical Society Reviews, and is a Fellow of the RSC. He has held both EPSRC Advanced and Leadership Fellowships and has been the recipient of the RSC Corday-Morgan medal (2013), the Marlow medal of the Faraday Division (2004) and the Harrison Memorial medal (2001).
University of Leeds
Ben Murray is a Professor of Atmospheric Science and holds a European Research Council (ERC) Consolidator fellowship in the Institute for Climate and Atmospheric Science in the University of Leeds.
His research addresses fundamental questions on atmospheric aerosol and their influence on ice formation in clouds as well as the properties of ice within clouds.
University of York
My research focuses on developing state of the art chromatographic and mass spectrometric techniques to study the composition of organic aerosols, a key method to understanding their formation and processing in the atmosphere.
Defence Science and Technology Laboratory
I am a Research Scientist working within the Microbiology Group at the Defence Science and Technology Laboratory (Dstl). Dstl provides specialist advice, services and facilities to the MoD and wider government, to maximise the impact of science and technology for the defence and security of the UK.
My area of interest is the decay of infectious biological aerosols under environmental conditions and the hazard they pose. I joined Dstl as a graduate in 2000 after completing a Bsc Biological Sciences with Virology at The University of Warwick. Whilst working at Dstl I completed my PhD entitled “The construction of defined mutants in Francisella species” in 2006 through the Open University.
Public Health England
I am currently Senior Aerosol Scientist in the Nanoparticle Inhalation Research Group, Toxicology Department, Public Health England. I previously worked as Senior Research Associate in the Atmospheric Chemistry Research Group, University of Bristol, having obtained Ph.D. (2011) and M.Sci. (2004) degrees in Physics, also at Bristol. My current main area of research involves studies on the aerosol characteristics, composition, lung deposition and toxicological effects associated with exposure to aerosolised carbon nanotubes, e-cigarette aerosol, and nanoparticle-enabled consumer products.
My other research interests include submicron and ultrafine aerosol size distributions in urban, rural, indoor and transport environments, development of gas and aerosol tracer technologies to study dispersion (including infiltration into buildings) and chemical reactivity in the urban atmosphere. Whilst at Bristol I was also involved in studies involving air pollution measurements in a SE Asian megacity (Bangkok, Thailand), ambient aerosol electric charge state and the potential influence on lung deposition in human volunteers, and the relationship between air ions, aerosols and atmospheric electricity in urban and other environments.
I have been an active member of the Aerosol Society throughout my postgraduate and postdoctoral career, and have served on the Committee for several years, most recently taking up the role of General Secretary in July 2018.
University of Hertfordshire
Prior to the role of Vice President, I had the pleasure of being President of the Aerosol Society from 2013 – 2017 and a Committee member since 2010, when I joined the University of Hertfordshire as Principal Lecturer in Pharmaceutics. In my academic career, I am now Associate Dean for Enterprise in the School of Life and Medical Sciences, where I also carry out my research in the Centre for Topical Drug Delivery and Toxicology (TDDT). I trained as a pharmacist initially, gaining a BSc. (Pharm.) from Trinity College Dublin and then a PhD in Pharmaceutical Technology from King’s College London.
My research focuses on improving drug delivery products for topical administration of medicines to patients, particularly for inhaled aerosol therapies. Aerosol science encompasses a diverse range of disciplines. In TDDT our contribution to aerosol science revolves around developing an understanding of how inhalable particles can be manufactured and processed such that that a stable formulation and product can be developed, to result in on-demand generation of a therapeutic aerosol by the patient. This also requires assessment of the biological exposure behaviour and responses after inhalation, and the development of advanced analytical techniques to assess product performance and use by patients.
University of Cambridge
Dr Adam Boies is a Lecturer in the Energy, Fluid Mechanics and Turbomachinery Engineering Division at the University of Cambridge and a fellow of Trinity College. His research focuses on gas-phase particle (aerosol) production and characterization.
He is director of the Advanced Nanotube Application and Manufacturing Initiative, (ANAM.eng.cam.ac.uk) which seeks to enhance throughput, increase functionality and apply CNT material produced from floating catalysts for purposes of fibre spinning and mat production. Other laboratory efforts include the production of nanoparticle catalysts by means of controlling charging behaviour with applications in the automotive catalyst sector. He is a lead investigator of transportation energy and emissions within the Centre for Sustainable Freight, which focus on developing analysis tools that demonstrate achievable reductions in energy use and emissions.
University of Cambridge
I have been a member of the Aerosol Society since its formation and have played an active role, including President, within the Society. I was made an honorary member in 2013.
I have written a number of books on aerosol science the most recent being “Aerosol Science – Technology and Applications”. Nowadays my research concentrates on indoor air quality, bioaerosols and the impact of nanoparticles on the environment.
At Essex, in addition to research and teaching I am Dean (PG Research and Education – Faculty of Science and Health) and University Appeals Officer.
University of Manchester
Amanda Lea-Langton currently works as a Lecturer in Bioenergy Engineering at the Tyndall Centre for Climate Change, School of Mechanical, Aerospace and Civil Engineering, The University of Manchester.
Amanda is experienced in the development of future fuels and emissions minimisation. She has a background in domestic wood burning emissions, emissions from diesel engines , and the development of sustainable technologies for transportation. Her work has involved a focus on feedstock upgrading and improved energy performance in terms of efficiency, waste products and emissions.
Her current research includes development of cleaner domestic stoves and sustainable transport solutions, and the whole system impacts including air quality and climate effects.
Defence Science and Technology Laboratory
Simon has a background in air quality, aerosol sampling and deposition from turbulent flows in a range of environments. He has worked on modelling and simulation of aerosol transport and dispersion, specialising in the built environment and enclosed spaces.
A postdoctoral researcher at the National University of Ireland, Galway working in Dr. Miriam Byrne’s group within the Centre for Climate and Air Pollution Studies. Graduated with a Ph.D. in 2014 at the National University of Ireland, Galway, and the thesis entitled “Development of a Probabilistic Multi-Zone Multi-Source Computational Model for Indoor Air Pollution Exposure Assessment”. The model focused on overcoming the uncertainties surrounding the parameterisation of previous exposure models. The model had the ability to fully assess the distribution of air pollutants under time-varying conditions throughout residential buildings.
My current research project is a computational study that examines the implications of radon concentrations following energy efficient retrofit scenarios based on the impacts of the Energy Efficiency Directive (2012/27/EU). Previous areas of research have incorporated thermal characteristics into the exposure model within a single computational structure. Simulating individuals’ thermal comfort and exposure to airborne pollutants, allowing an assessment of the heat loss to surroundings as a result of changes in ventilation rates.
A past recipient of the Aerosol Society’s C N Davies Award and the Aerosol Society’s Early Career Scientist travel grant which was to attend the Indoor Air 2014 Conference in Hong Kong, and the Healthy Buildings Conference in Eindhoven, 2015. Co-opted onto the Aerosol Society Committee at the Annual Aerosol Conference in Birmingham in November 2014, and elected an ordinary committee member the following year.
Gary has extensive experience in the technical leadership of inhaled drug delivery and development in both pharma and CRO organisations.
He is a recognised expert in inhalation sciences across the industry, and current Chair of the Society’s ‘Drug Delivery to the Lungs’ (DDL) international conference.
University of Manchester
I am a Research Fellow for the National Centre for Atmospheric Science (NCAS), based at the University of Manchester. Part of my work is as an instrument scientist for the Atmospheric Measurement Facility (AMF), which is a support facility for NCAS providing a suite of aerosol instrumentation for use by Universities and industry alike.
My other activities include research into the physical and chemical properties of aerosol particles in our atmosphere, making measurements from sea level up to 30,000 ft. I also have an interest in aircraft particulate emissions, especially from the emerging regulatory perspective.
National Physical Laboratory
Dave Worton is a Senior Research Scientist leading the Environmental Gases team of NPL’s Gas and Particle Metrology Group. His work focuses on providing the traceability that underpins global atmospheric and urban air quality monitoring of greenhouse gases, emission and reactive gases and volatile organic compounds.
He received a First Class Bachelor’s degree in Chemistry from the University of Nottingham, a Master’s degree with distinction in Environmental Geochemistry from the University of Leeds, and a PhD in Atmospheric Chemistry from the University of East Anglia. Prior to joining NPL in 2015, he was a research specialist at the University of California, Berkeley, focused on developing and applying novel instrumentation to better characterize the organic composition of atmospheric particles and petrochemicals with implications for climate, air quality and human health.
Dave has over 10 years’ experience of analysing gas phase and particulate bound organic compounds using gas chromatography and mass spectrometry techniques and has published over 40 peer-reviewed papers. He is a member of the Royal Society of Chemistry and represents NPL on the BSI EH/2/3, CEN TC264 WG12 and ISO TC24/SC4 standardisation committees.
Kings College London
Ben Forbes is Professor of Pharmaceutics at King’s College London. He has a BPharm from King’s College London (1987) and a PhD in Drug Delivery from Strathclyde University (1996).Before doctoral studies, he worked in hospital pharmacy in London and Sydney, and for Inveresk Clinical Research in Edinburgh. Professor Forbes was appointed to the academic staff of King’s College London in 1997. He is a registered pharmacist in the UK.
He originated the term ‘Inhalation biopharmaceutics’ to describe the factors that influence the rate and extent of drug absorption from the lungs and has authored many publications in this area, including: (1) inhaled medicine formulation, (2) the development and application of techniques to study respiratory drug transport and metabolism, (3) respiratory toxicology/disease.
He is founder and coordinator of the APSGB ‘Drug Delivery to the Lungs’ Network, a UK-based international academia-industry-regulatory group dedicated to pre-competitive collaboration: www.apsgb.org/drugsinthelungs/